BIOLOGICAL · Unmapped registry intervention
T cell vaccination
Find medicine records ·
Find other trials using this name
Clinical trial
TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis
NCT00228228
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedTCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple Sclerosis
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Multiple Sclerosisverified · MONDO: multiple sclerosis
Interventions
T cell vaccinationBIOLOGICAL
Sponsors & collaborators
Sheba Medical Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00228228 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.